A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

December 31, 2004

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Micellar Paclitaxel for Injection

Trial Locations (9)

32114

Radiant Research, Daytona Beach

33614

Tampa Medical Group Research, Tampa

34474

Ocala Rheumatology Research Center, Ocala

46202

Indiana University, Indianapolis

80230

Denver Arthritis Clinic, Denver

89502

Arthritis Center of Reno, Reno

35294-7201

University of Alabama at Birmingham, Birmingham

67214-4976

Arthritis & Rheumatology Clinic of Kansas, Wichita

16635-1018

Altoona Center for Research, Duncansville

Sponsors
All Listed Sponsors
lead

Angiotech Pharmaceuticals

INDUSTRY

NCT00055133 - A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter